Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $10.04 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.98.
Market Cap
10.04T
Revenue
4.74T
Profits
213.65B
PE Ratio
46.98
Profit Margin
4.51%
Dividend Yield
0.37%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.27T | -0.70% | 2,412,050 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 682.52B | 1.11% | 8,806,506 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 520.47B | -0.18% | 4,826,816 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 363.01B | 0.54% | 3,918,136 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 362.27B | -0.16% | 6,108,080 | 67.38B |
| 6 | NVS | Novartis AG | 303.68B | -0.04% | 2,138,479 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 285.96B | -0.59% | 1,709,502 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 259.15B | -2.55% | 1,685,529 | 47.35B |
| 9 | AMGN | Amgen Inc. | 252.64B | -0.22% | 2,827,909 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 208.31B | -1.05% | 4,233,733 | 30.99B |
| 11 | ABT | Abbott Laboratories | 185.75B | -1.87% | 9,955,128 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 179.86B | -1.07% | 15,749,512 | 50.70B |
| 13 | PFE | Pfizer Inc. | 164.33B | -2.11% | 30,780,121 | 63.62B |
| 14 | DHR | Danaher Corporation | 163.33B | -1.34% | 2,382,362 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 152.49B | -2.14% | 1,794,399 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 137.57B | -0.81% | 984,588 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.39B | -0.94% | 9,390,193 | 50.03B |
| 18 | MCK | McKesson Corporation | 124.35B | -0.25% | 539,000 | 418.79B |
| 19 | MDT | Medtronic plc | 123.63B | -0.61% | 6,102,583 | 37.54B |
| 20 | SYK | Stryker Corporation | 118.92B | -2.01% | 2,435,501 | 26.30B |
| 21 | SNY | Sanofi | 116.56B | 0.06% | 2,364,917 | 57.89B |
| 22 | CVS | CVS Health Corporation | 114.88B | 0.30% | 11,792,301 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.58B | -1.06% | 817,827 | 78.70B |
| 24 | GSK | GSK plc | 100.87B | 0.08% | 2,546,636 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 95.45B | -0.86% | 1,211,309 | 16.90B |
| 26 | MRNA | Moderna, Inc. | 93.61B | -6.97% | 7,021,334 | 2.53B |
| 27 | ELV | Elevance Health, Inc. | 92.88B | 0.10% | 943,192 | 201.83B |
| 28 | CI | The Cigna Group | 78.07B | -1.72% | 1,622,216 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.16B | 1.34% | 3,264,980 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.67B | -0.14% | 997,746 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.29B | 0.25% | 1,295,633 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 64.07B | -2.06% | 11,505,058 | 21.07B |
| 33 | ARGX | argenx SE | 61.31B | 0.38% | 449,423 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 60.84B | -0.01% | 4,178,650 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 58.76B | 0.55% | 1,762,438 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.99B | -0.65% | 487,643 | 4.66B |
| 37 | HUM | Humana Inc. | 53.29B | -0.59% | 1,936,063 | 154.19B |
| 38 | MDLN | Medline Inc. | 52.59B | -5.17% | 9,846,992 | 30.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 50.93B | 0.95% | 9,251,163 | 17.23B |
| 40 | VEEV | Veeva Systems Inc. | 48.96B | -0.77% | 791,181 | 3.46B |
| 41 | A | Agilent Technologies, Inc. | 48.78B | -2.23% | 1,714,820 | 7.37B |
| 42 | ONC | BeOne Medicines AG | 47.51B | -0.96% | 342,715 | 6.45B |
| 43 | NTRA | Natera, Inc. | 46.83B | 0.98% | 1,500,785 | 2.91B |
| 44 | WAT | Waters Corporation | 45.43B | -1.85% | 557,850 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 44.68B | -1.25% | 1,041,121 | 17.31B |
| 46 | HLN | Haleon plc | 39.70B | -0.11% | 18,244,893 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.56B | -1.49% | 3,784,553 | 2.62B |
| 48 | RVMD | Revolution Medicines, Inc. | 38.14B | -2.41% | 3,222,401 | 197.56M |
| 49 | BIIB | Biogen Inc. | 37.03B | -1.15% | 792,515 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 37.00B | -0.92% | 2,673,740 | 21.64B |
| 51 | CNC | Centene Corporation | 34.79B | -0.30% | 3,701,414 | 180.41B |
| 52 | ALC | Alcon Inc. | 34.69B | -0.87% | 2,252,079 | 10.98B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.43B | -1.03% | 117,307 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 33.71B | 0.47% | 4,389,343 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.60B | 0.43% | 1,088,990 | 5.73B |
| 56 | GMAB | Genmab A/S | 33.05B | -3.95% | 5,627,969 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 31.68B | -1.59% | 1,726,505 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.35B | 1.29% | 4,087,160 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.23B | 0.02% | 519,332 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.47B | -0.50% | 1,351,723 | 20.16B |
| 61 | ROIV | Roivant Sciences Ltd. | 28.98B | -4.44% | 8,744,049 | 41.08M |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.65B | -0.38% | 378,122 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.57B | 0.37% | 841,564 | 11.84B |
| 64 | INSM | Insmed Incorporated | 25.90B | -2.22% | 2,397,944 | 1.52B |
| 65 | UTHR | United Therapeutics Corporation | 25.27B | -0.39% | 338,727 | 3.19B |
| 66 | INCY | Incyte Corporation | 24.81B | -0.47% | 1,008,921 | 6.01B |
| 67 | STE | STERIS plc | 24.61B | -1.10% | 517,498 | 6.17B |
| 68 | VTRS | Viatris Inc. | 23.70B | -1.85% | 8,788,386 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.83B | -2.09% | 639,975 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.08B | -2.98% | 979,097 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.98B | -2.00% | 3,516,265 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.95B | 0.05% | 3,334,183 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.79B | -2.71% | 1,668,141 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.37B | -1.19% | 142,184 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.53B | -0.78% | 1,467,527 | 2.94B |
| 76 | ASND | Ascendis Pharma A/S | 17.52B | 3.00% | 1,281,398 | 1.37B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 17.15B | -2.87% | 1,345,859 | 3.70B |
| 78 | EXEL | Exelixis, Inc. | 17.04B | -1.22% | 1,631,824 | 2.50B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.33B | -0.55% | 902,121 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.43B | -3.17% | 584,416 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.23B | -1.72% | 1,804,222 | 945.54M |
| 82 | SOLV | Solventum Corporation | 15.07B | 0.21% | 1,014,517 | 8.16B |
| 83 | ICLR | ICON Public Limited Company | 15.02B | 0.41% | 779,978 | 8.23B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.88B | -1.61% | 1,601,124 | 15.25B |
| 85 | GKOS | Glaukos Corporation | 14.56B | -0.46% | 808,480 | 690.33M |
| 86 | TEM | Tempus AI, Inc. | 13.84B | -4.46% | 4,822,256 | 1.51B |
| 87 | EHC | Encompass Health Corporation | 13.82B | -0.99% | 635,028 | 6.34B |
| 88 | BAX | Baxter International Inc. | 13.32B | -2.28% | 4,668,667 | 11.61B |
| 89 | ELAN | Elanco Animal Health Incorporated | 13.25B | 0.08% | 4,315,070 | 5.15B |
| 90 | SNN | Smith & Nephew plc | 12.96B | -0.13% | 945,938 | 6.30B |
| 91 | PEN | Penumbra, Inc. | 12.64B | -0.30% | 214,271 | 1.56B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 12.20B | -0.74% | 1,654,035 | 3.44B |
| 93 | SMMT | Summit Therapeutics Inc. | 12.06B | -9.41% | 3,882,138 | - |
| 94 | COO | The Cooper Companies, Inc. | 11.83B | -1.18% | 1,949,507 | 4.24B |
| 95 | ALGN | Align Technology, Inc. | 11.77B | -2.97% | 790,074 | 4.16B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.48B | -0.99% | 1,430,975 | 1.80B |
| 97 | TECH | Bio-Techne Corporation | 11.44B | 0.05% | 2,191,768 | 1.23B |
| 98 | FMS | Fresenius Medical Care AG | 11.35B | -2.79% | 2,870,270 | 22.12B |
| 99 | UHS | Universal Health Services, Inc. | 11.18B | -1.49% | 440,895 | 18.35B |
| 100 | MTRI | Mentari Therapeutics, Inc. | 11.03B | 17.55% | 145,626 | - |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.98B | -2.79% | 1,941,526 | 3.66B |
| 102 | DVA | DaVita Inc. | 10.95B | -5.14% | 834,710 | 14.17B |
| 103 | MOH | Molina Healthcare, Inc. | 10.93B | 0.29% | 598,500 | 42.08B |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.86B | -5.69% | 685,032 | 102.24M |
| 105 | ENSG | The Ensign Group, Inc. | 10.79B | 0.19% | 246,732 | 5.67B |
| 106 | RGEN | Repligen Corporation | 10.64B | -3.53% | 802,979 | 805.61M |
| 107 | AVTR | Avantor, Inc. | 10.58B | -0.70% | 3,644,023 | 6.64B |
| 108 | PODD | Insulet Corporation | 10.36B | -0.49% | 745,765 | 3.19B |
| 109 | QGEN | Qiagen N.V. | 10.35B | -0.40% | 4,241,040 | 2.12B |
| 110 | PCVX | Vaxcyte, Inc. | 10.24B | -5.73% | 1,072,465 | - |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.96B | -4.02% | 182,322 | 2.59B |
| 112 | OSCR | Oscar Health, Inc. | 9.91B | -0.53% | 3,659,612 | 17.47B |
| 113 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.88B | -1.81% | 391,331 | 1.43B |
| 114 | HNGE | Hinge Health, Inc. | 9.83B | -0.60% | 743,539 | 800.82M |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.77B | -3.66% | 985,835 | - |
| 116 | GMED | Globus Medical, Inc. | 9.58B | -4.10% | 1,694,662 | 3.14B |
| 117 | HSIC | Henry Schein, Inc. | 9.52B | -2.58% | 1,085,693 | 13.73B |
| 118 | BRKR | Bruker Corporation | 9.21B | -3.33% | 1,511,003 | 3.51B |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.08B | -6.20% | 590,079 | 7.46M |
| 120 | KRYS | Krystal Biotech, Inc. | 9.06B | -1.01% | 157,100 | 470.03M |
| 121 | TGTX | TG Therapeutics, Inc. | 9.04B | -1.82% | 1,580,865 | 897.76M |
| 122 | ATR | AptarGroup, Inc. | 8.98B | -0.60% | 338,203 | 3.99B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.77B | -0.36% | 542,900 | 551.69M |
| 124 | HQY | HealthEquity, Inc. | 8.52B | 0.02% | 495,106 | 1.36B |
| 125 | CORT | Corcept Therapeutics Incorporated | 8.07B | -1.10% | 847,073 | 963.65M |
| 126 | ABVX | ABIVAX Société Anonyme | 7.95B | -1.36% | 692,055 | 5.33M |
| 127 | ALKS | Alkermes plc | 7.89B | -1.90% | 3,125,558 | 1.75B |
| 128 | CYTK | Cytokinetics, Incorporated | 7.82B | -4.05% | 2,009,166 | 113.29M |
| 129 | TXG | 10x Genomics, Inc. | 7.77B | -4.75% | 2,741,102 | 618.58M |
| 130 | GRFS | Grifols, S.A. | 7.70B | -0.45% | 738,239 | 8.63B |
| 131 | PACS | PACS Group, Inc. | 7.62B | -4.12% | 628,869 | 5.71B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.62B | -2.05% | 1,064,819 | 280.75M |
| 133 | AXSM | Axsome Therapeutics, Inc. | 7.59B | -3.26% | 979,635 | 865.27M |
| 134 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.56B | 0.54% | 368,781 | 945.96M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.56B | -0.05% | 1,559,993 | 3.20B |
| 136 | BLCO | Bausch + Lomb Corporation | 7.56B | -0.84% | 823,946 | 5.42B |
| 137 | IMVT | Immunovant, Inc. | 7.25B | -5.37% | 1,182,856 | - |
| 138 | TWST | Twist Bioscience Corporation | 7.16B | -6.83% | 5,302,877 | 459.43M |
| 139 | CHE | Chemed Corporation | 7.13B | -0.08% | 104,678 | 2.66B |
| 140 | ORKA | Oruka Therapeutics, Inc. | 7.12B | -2.03% | 1,141,885 | - |
| 141 | CAI | Caris Life Sciences, Inc. | 6.87B | -2.16% | 3,571,760 | 1.05B |
| 142 | BLTE | Belite Bio, Inc | 6.84B | 8.99% | 496,545 | - |
| 143 | KOD | Kodiak Sciences Inc. | 6.79B | -1.00% | 561,200 | - |
| 144 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.67B | -4.48% | 2,164,346 | 450.82M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.62B | -0.34% | 1,193,847 | 1.56B |
| 146 | IBRX | ImmunityBio, Inc. | 6.46B | -9.00% | 21,024,020 | 182.57M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | -0.18% | 248,304 | 253.83M |
| 148 | CGON | CG Oncology, Inc. | 6.27B | -3.39% | 1,277,771 | 6.17M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.09B | -1.35% | 392,856 | 670.78M |
| 150 | TFX | Teleflex Incorporated | 6.07B | -2.03% | 604,041 | 2.26B |
| 151 | SUPN | Supernus, Inc. | 6.07B | -0.85% | 4,365,970 | 1.37B |
| 152 | RDNT | RadNet, Inc. | 5.99B | -2.61% | 408,019 | 2.38B |
| 153 | DOCS | Doximity, Inc. | 5.92B | -0.06% | 1,950,073 | 661.58M |
| 154 | MANE | Veradermics, Incorporated | 5.71B | -13.59% | 2,305,510 | - |
| 155 | HAE | Haemonetics Corporation | 5.59B | 1.80% | 597,594 | 1.38B |
| 156 | ERAS | Erasca, Inc. | 5.54B | -6.07% | 4,897,369 | - |
| 157 | GRAL | GRAIL, Inc. | 5.46B | -3.41% | 596,904 | 166.60M |
| 158 | CON | Concentra Group Holdings Parent, Inc. | 5.44B | -1.06% | 798,644 | 2.34B |
| 159 | WAY | Waystar Holding Corp. | 5.41B | -2.43% | 1,387,504 | 1.26B |
| 160 | LFST | LifeStance Health Group, Inc. | 5.38B | -1.53% | 5,017,664 | 1.68B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.29B | -2.39% | 538,718 | 1.16B |
| 162 | BLLN | BillionToOne, Inc. | 5.29B | 0.51% | 582,289 | 436.87M |
| 163 | HTFL | HeartFlow, Inc. | 5.27B | 1.39% | 4,326,585 | 238.66M |
| 164 | SRRK | Scholar Rock Holding Corporation | 5.27B | -7.38% | 1,378,619 | 570.00K |
| 165 | LQDA | Liquidia Corporation | 5.24B | 5.27% | 2,967,875 | 621.87M |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 3.56% | 921,026 | 2.72M |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.19B | -1.57% | 540,030 | 1.61B |
| 168 | COGT | Cogent Biosciences, Inc. | 5.07B | -0.88% | 1,858,757 | - |
| 169 | MMED | MiniMed Group, Inc. | 5.03B | -2.05% | 3,271,470 | 3.22B |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 5.02B | -3.68% | 1,097,357 | - |
| 171 | LIVN | LivaNova PLC | 4.97B | -0.86% | 465,912 | 1.51B |
| 172 | TVTX | Travere Therapeutics, Inc. | 4.95B | -0.92% | 590,308 | 651.03M |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.77B | -1.54% | 1,920,480 | 298.01M |
| 174 | OPCH | Option Care Health, Inc. | 4.75B | -0.06% | 3,233,052 | 5.75B |
| 175 | SHC | Sotera Health Company | 4.66B | -0.85% | 2,451,109 | 1.23B |
| 176 | HIMS | Hims & Hers Health, Inc. | 4.62B | -5.19% | 13,670,497 | 2.87B |
| 177 | IONS | Ionis Pharmaceuticals, Inc. | 4.55B | -3.60% | 6,201,342 | 960.09M |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.52B | -4.26% | 1,202,803 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.43B | -0.54% | 290,534 | 2.18B |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | -0.21% | 393,295 | 1.83B |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.21B | -3.42% | 3,488,386 | 53.81M |
| 182 | CDNA | CareDx, Inc. | 4.19B | -1.68% | 685,843 | 497.40M |
| 183 | CRSP | CRISPR Therapeutics AG | 4.13B | -6.84% | 2,493,021 | 25.17M |
| 184 | XENE | Xenon Pharmaceuticals Inc. | 4.03B | -2.62% | 1,223,579 | 7.50M |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.99B | -8.32% | 2,768,503 | 10.35M |
| 186 | NVST | Envista Holdings Corporation | 3.95B | -2.61% | 2,272,446 | 2.88B |
| 187 | STVN | Stevanato Group S.p.A. | 3.92B | 3.24% | 879,108 | 1.42B |
| 188 | PLSE | Pulse Biosciences, Inc. | 3.84B | -8.30% | 355,975 | 1.49M |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.84B | -6.10% | 1,473,328 | -665.00K |
| 190 | TARS | Tarsus Pharmaceuticals, Inc. | 3.79B | 0.17% | 445,182 | 682.20M |
| 191 | IRON | Disc Medicine, Inc. | 3.79B | -4.42% | 761,217 | - |
| 192 | ABCL | AbCellera Biologics Inc. | 3.77B | -2.76% | 3,155,013 | 67.85M |
| 193 | OGN | Organon & Co. | 3.65B | 0.07% | 2,903,668 | 6.10B |
| 194 | LEGN | Legend Biotech Corporation | 3.60B | -5.12% | 4,449,312 | 1.36B |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.56B | -5.63% | 917,127 | - |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.53B | -5.69% | 10,387,911 | 378.98M |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.52B | -3.02% | 2,190,813 | - |
| 198 | ACHC | Acadia Healthcare Company, Inc. | 3.52B | -2.55% | 1,674,172 | 3.41B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -3.00% | 1,894,644 | 508.68M |
| 200 | VRDN | Viridian Therapeutics, Inc. | 3.46B | -2.46% | 1,951,102 | 26.31M |
| 201 | SGRY | Surgery Partners, Inc. | 3.45B | -0.30% | 3,466,917 | 3.36B |
| 202 | PBLS | Parabilis Medicines, Inc. | 3.42B | -6.61% | 806,102 | 2.26M |
| 203 | WRBY | Warby Parker Inc. | 3.32B | -11.34% | 6,261,674 | 934.66M |
| 204 | AXGN | Axogen, Inc. | 3.31B | -5.51% | 3,055,458 | 266.93M |
| 205 | NHC | National HealthCare Corporation | 3.30B | 0.19% | 64,911 | 1.58B |
| 206 | TMDX | TransMedics Group, Inc. | 3.20B | -0.01% | 1,054,604 | 727.65M |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.19B | -5.45% | 2,312,022 | - |
| 208 | CELC | Celcuity Inc. | 3.15B | -0.23% | 906,768 | - |
| 209 | IRTC | iRhythm Holdings, Inc. | 3.15B | 5.50% | 1,390,284 | 854.04M |
| 210 | TLX | Telix Pharmaceuticals Limited | 3.14B | -3.80% | 251,938 | 890.79M |
| 211 | ACAD | Acadia Pharmaceuticals Inc. | 3.14B | -1.25% | 1,934,198 | 1.20B |
| 212 | GRDN | Guardian Pharmacy Services, Inc. | 3.13B | -1.20% | 388,603 | 1.46B |
| 213 | BHC | Bausch Health Companies Inc. | 3.09B | -1.20% | 2,350,370 | 11.11B |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 3.04B | -3.76% | 615,932 | 36.54M |
| 215 | XERS | Xeris Biopharma Holdings, Inc. | 3.04B | 0.79% | 2,270,019 | 368.26M |
| 216 | DNLI | Denali Therapeutics Inc. | 3.03B | -4.26% | 1,309,620 | 21.38M |
| 217 | PRVA | Privia Health Group, Inc. | 3.02B | -1.54% | 1,326,405 | 2.43B |
| 218 | ADMA | ADMA Biologics, Inc. | 2.94B | 0.38% | 3,092,334 | 519.15M |
| 219 | VCEL | Vericel Corporation | 2.93B | -3.41% | 826,630 | 324.17M |
| 220 | ZLAB | Zai Lab Limited | 2.93B | -1.44% | 859,416 | 441.73M |
| 221 | XNCR | Xencor, Inc. | 2.86B | -4.60% | 1,214,593 | 200.49M |
| 222 | ATRC | AtriCure, Inc. | 2.85B | -2.69% | 462,488 | 589.80M |
| 223 | MBX | MBX Biosciences, Inc. | 2.71B | -5.56% | 321,987 | - |
| 224 | PGNY | Progyny, Inc. | 2.69B | 0.22% | 795,066 | 1.34B |
| 225 | AVAH | Aveanna Healthcare Holdings Inc. | 2.67B | -6.49% | 4,738,843 | 2.68B |
| 226 | CLOV | Clover Health Investments, Corp. | 2.61B | -1.81% | 4,138,511 | 2.74B |
| 227 | HCM | HUTCHMED (China) Limited | 2.61B | -1.53% | 24,795 | 549.12M |
| 228 | RCUS | Arcus Biosciences, Inc. | 2.56B | -5.48% | 1,097,936 | 100.00M |
| 229 | RGC | Regencell Bioscience Holdings Limited | 2.54B | -5.27% | 163,728 | - |
| 230 | ARDT | Ardent Health, Inc. | 2.49B | -2.80% | 626,233 | 6.45B |
| 231 | NEOG | Neogen Corporation | 2.44B | -3.53% | 1,631,502 | 884.00M |
| 232 | BEAM | Beam Therapeutics Inc. | 2.40B | -6.90% | 1,511,772 | 146.64M |
| 233 | NAMS | NewAmsterdam Pharma Company N.V. | 2.40B | -3.62% | 2,278,900 | 25.94M |
| 234 | MD | Pediatrix Medical Group, Inc. | 2.39B | -0.16% | 376,897 | 1.96B |
| 235 | PHVS | Pharvaris N.V. | 2.38B | -1.02% | 376,268 | - |
| 236 | UFPT | UFP Technologies, Inc. | 2.37B | -2.59% | 51,840 | 649.52M |
| 237 | SDGR | Schrödinger, Inc. | 2.32B | -2.13% | 1,359,387 | 269.20M |
| 238 | ADUS | Addus HomeCare Corporation | 2.26B | -1.41% | 135,731 | 1.50B |
| 239 | PRGO | Perrigo Company plc | 2.25B | -2.24% | 1,379,843 | 4.09B |
| 240 | CLDX | Celldex Therapeutics, Inc. | 2.24B | -5.37% | 867,096 | 158.00K |
| 241 | PVLA | Palvella Therapeutics, Inc. | 2.24B | -6.56% | 282,768 | - |
| 242 | IMNM | Immunome, Inc. | 2.21B | -1.94% | 1,658,662 | 4.02M |
| 243 | ALMR | Alamar Biosciences, Inc. | 2.21B | 0.47% | 430,436 | 114.05M |
| 244 | LKFT | Lakefront Biotherapeutics NV | 2.20B | 1.77% | 535,522 | 1.13B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | 0.00% | 625,065 | 321.74M |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.15B | -0.71% | 1,793,088 | 1.08B |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | 2.60% | 550,302 | 1.17B |
| 248 | BKD | Brookdale Senior Living Inc. | 2.14B | -2.82% | 12,000,047 | 2.86B |
| 249 | NEO | NeoGenomics, Inc. | 2.14B | -1.72% | 1,353,310 | 787.75M |
| 250 | BHVN | Biohaven Ltd. | 2.13B | -7.37% | 1,629,437 | - |
| 251 | VERA | Vera Therapeutics, Inc. | 2.10B | -4.72% | 913,893 | 10.28M |
| 252 | REPL | Replimune Group, Inc. | 2.08B | 0.92% | 2,892,202 | - |
| 253 | RXRX | Recursion Pharmaceuticals, Inc. | 2.08B | -7.24% | 20,569,041 | 68.23M |
| 254 | VIR | Vir Biotechnology, Inc. | 2.08B | -7.69% | 2,061,465 | 302.80M |
| 255 | ESTA | Establishment Labs Holdings Inc. | 2.05B | -2.93% | 314,974 | 264.03M |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 2.05B | -3.62% | 311,347 | - |
| 257 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | -0.26% | 2,504,485 | 213.00M |
| 258 | SEPN | Septerna, Inc. | 1.99B | -13.80% | 608,544 | 96.27M |
| 259 | VCYT | Veracyte, Inc. | 1.99B | -1.91% | 2,507,928 | 581.78M |
| 260 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -1.23% | 936,222 | 989.36M |
| 261 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.98B | 0.39% | 3,572,330 | 961.51M |
| 262 | MAZE | Maze Therapeutics, Inc. | 1.97B | -1.74% | 451,366 | 20.00M |
| 263 | TRVI | Trevi Therapeutics, Inc. | 1.94B | -8.07% | 2,014,851 | - |
| 264 | FTRE | Fortrea Holdings Inc. | 1.94B | -1.57% | 1,594,386 | 2.67B |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -3.23% | 497,039 | 140.84M |
| 266 | LYCA | Lycia Therapeutics, Inc. | 1.89B | 4.42% | 496,081 | 4.44M |
| 267 | ZBIO | Zenas BioPharma, Inc. | 1.87B | -3.69% | 752,030 | 11.00M |
| 268 | AGL | agilon health, inc. | 1.85B | -3.93% | 161,580 | 6.00B |
| 269 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | 0.13% | 426,193 | - |
| 270 | AZTA | Azenta, Inc. | 1.83B | -10.31% | 910,543 | 621.70M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 1.83B | -5.33% | 5,492,192 | 3.58B |
| 272 | ZYME | Zymeworks Inc. | 1.83B | -8.94% | 1,331,917 | 265.97M |
| 273 | CERT | Certara, Inc. | 1.82B | 1.45% | 3,122,969 | 425.76M |
| 274 | BFLY | Butterfly Network, Inc. | 1.78B | -6.58% | 3,789,463 | 123.26M |
| 275 | LMAT | LeMaitre Vascular, Inc. | 1.78B | -2.07% | 166,324 | 269.36M |
| 276 | ETON | Eton Pharmaceuticals, Inc. | 1.77B | -10.16% | 1,017,322 | 141.06M |
| 277 | INSP | Inspire Medical Systems, Inc. | 1.75B | -2.53% | 542,462 | 880.94M |
| 278 | MESO | Mesoblast Limited | 1.73B | -4.03% | 184,226 | 120.25M |
| 279 | QURE | uniQure N.V. | 1.73B | 0.16% | 2,133,218 | 20.17M |
| 280 | PSNL | Personalis, Inc. | 1.72B | -0.63% | 1,864,833 | 80.77M |
| 281 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -4.02% | 2,210,975 | 1.96B |
| 282 | KLRA | Kailera Therapeutics, Inc. | 1.72B | -8.14% | 563,118 | - |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.71B | -5.62% | 501,226 | 28.21M |
| 284 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | -9.52% | 531,491 | 106.73M |
| 285 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -4.47% | 1,338,482 | 701.94M |
| 286 | HCSG | Healthcare Services Group, Inc. | 1.69B | -0.75% | 357,313 | 1.88B |
| 287 | BRVE | Braveheart Bio, Inc. | 1.67B | -1.91% | 256,072 | - |
| 288 | PGEN | Precigen, Inc. | 1.67B | -1.27% | 5,318,329 | 156.94M |
| 289 | ADRX | ADARx Pharmaceuticals, Inc. | 1.67B | 12.11% | 994,943 | 6.13M |
| 290 | ALVO | Alvotech | 1.67B | -5.08% | 2,990,092 | 492.31M |
| 291 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | -2.57% | 3,617,074 | 730.00M |
| 292 | NBTX | Nanobiotix S.A. | 1.63B | -2.12% | 171,117 | 13.15M |
| 293 | ASTH | Astrana Health, Inc. | 1.63B | -3.55% | 334,732 | 3.91B |
| 294 | SLS | SELLAS Life Sciences Group, Inc. | 1.62B | -4.63% | 4,380,246 | - |
| 295 | GENB | Generate Biomedicines, Inc. | 1.61B | -6.82% | 1,608,184 | 21.07M |
| 296 | OMCL | Omnicell, Inc. | 1.61B | -1.74% | 273,949 | 1.24B |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.61B | -2.36% | 323,472 | 593.56M |
| 298 | ENOV | Enovis Corporation | 1.59B | -3.19% | 1,153,274 | 2.31B |
| 299 | TDOC | Teladoc Health, Inc. | 1.58B | -2.80% | 3,142,130 | 2.47B |
| 300 | ABSI | Absci Corporation | 1.58B | -9.73% | 4,918,283 | 1.49M |
| 301 | IMCR | Immunocore Holdings plc | 1.57B | -3.71% | 460,993 | 429.30M |
| 302 | ALHC | Alignment Healthcare, Inc. | 1.57B | -2.47% | 3,666,344 | 4.94B |
| 303 | WGS | GeneDx Holdings Corp. | 1.55B | -5.90% | 916,427 | 460.78M |
| 304 | RAPP | Rapport Therapeutics, Inc. | 1.53B | -4.33% | 568,427 | 20.00M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | -0.04% | 361,301 | 1.04B |
| 306 | CNMD | CONMED Corporation | 1.50B | -0.57% | 217,926 | 1.37B |
| 307 | NTLA | Intellia Therapeutics, Inc. | 1.48B | -7.54% | 4,004,652 | 52.89M |
| 308 | USPH | U.S. Physical Therapy, Inc. | 1.47B | -1.50% | 139,786 | 829.86M |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.00% | 804,535 | 743.30M |
| 310 | NVAX | Novavax, Inc. | 1.45B | -12.22% | 7,014,017 | 411.65M |
| 311 | AMN | AMN Healthcare Services, Inc. | 1.44B | -1.27% | 490,614 | 3.52B |
| 312 | PAHC | Phibro Animal Health Corporation | 1.44B | 0.88% | 130,128 | 1.54B |
| 313 | LMRI | Lumexa Imaging Holdings, Inc. | 1.44B | -6.33% | 397,702 | 1.06B |
| 314 | NUVB | Nuvation Bio Inc. | 1.43B | -5.36% | 5,638,447 | 201.73M |
| 315 | KRSA | Korsana Biosciences, Inc. | 1.42B | -1.76% | 167,583 | - |
| 316 | ANAB | AnaptysBio, Inc. | 1.42B | -2.05% | 262,898 | 60.04M |
| 317 | GPCR | Structure Therapeutics Inc. | 1.41B | -5.30% | 1,038,141 | - |
| 318 | OCUL | Ocular Therapeutix, Inc. | 1.38B | -5.71% | 2,337,462 | 50.38M |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.37B | -5.03% | 439,163 | - |
| 320 | TSHA | Taysha Gene Therapies, Inc. | 1.37B | -1.64% | 3,880,632 | 5.49M |
| 321 | MLYS | Mineralys Therapeutics, Inc. | 1.37B | -4.08% | 2,929,504 | - |
| 322 | NVCR | NovoCure Limited | 1.37B | -2.25% | 1,246,673 | 725.39M |
| 323 | TYRA | Tyra Biosciences, Inc. | 1.37B | -5.75% | 857,076 | - |
| 324 | DMRA | Damora Therapeutics, Inc. | 1.36B | -5.16% | 671,094 | - |
| 325 | AVLN | Avalyn Pharma Inc. | 1.36B | -3.26% | 499,881 | - |
| 326 | PRCT | PROCEPT BioRobotics Corporation | 1.35B | 0.73% | 1,347,893 | 352.31M |
| 327 | INVA | Innoviva, Inc. | 1.35B | 0.58% | 563,822 | 438.32M |
| 328 | STAA | STAAR Surgical Company | 1.34B | 0.34% | 742,449 | 328.27M |
| 329 | MNKD | MannKind Corporation | 1.34B | -0.72% | 3,505,030 | 413.37M |
| 330 | KARD | Kardigan, Inc. | 1.32B | -9.95% | 345,772 | - |
| 331 | AAPG | Ascentage Pharma Group International | 1.32B | 0.13% | 2,439 | 94.61M |
| 332 | OMER | Omeros Corporation | 1.30B | -0.88% | 810,077 | 38.42M |
| 333 | URGN | UroGen Pharma Ltd. | 1.29B | 1.11% | 970,265 | 250.25M |
| 334 | CMPS | COMPASS Pathways plc | 1.29B | -1.94% | 2,387,741 | - |
| 335 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -3.14% | 226,488 | 1.30M |
| 336 | INNV | InnovAge Holding Corp. | 1.28B | -1.05% | 310,120 | 1.02B |
| 337 | NKTR | Nektar Therapeutics | 1.27B | -3.10% | 775,137 | 52.19M |
| 338 | SVRA | Savara Inc. | 1.27B | -5.41% | 4,297,079 | - |
| 339 | GHRS | GH Research PLC | 1.27B | -3.95% | 191,866 | - |
| 340 | PNTG | The Pennant Group, Inc. | 1.26B | -2.42% | 299,811 | 1.17B |
| 341 | CRON | Cronos Group Inc. | 1.25B | -1.16% | 939,419 | 206.20M |
| 342 | OPK | OPKO Health, Inc. | 1.24B | -2.34% | 2,547,005 | 654.10M |
| 343 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -4.71% | 612,803 | - |
| 344 | SLN | Silence Therapeutics plc | 1.23B | 0.15% | 659,205 | 615.00K |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.23B | 0.94% | 374,915 | 745.79M |
| 346 | ANRO | Alto Neuroscience, Inc. | 1.23B | -1.70% | 1,288,571 | - |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | -6.71% | 2,260,966 | 1.08B |
| 348 | GDRX | GoodRx Holdings, Inc. | 1.20B | -3.84% | 739,298 | 785.23M |
| 349 | VOR | Vor Biopharma Inc. | 1.19B | -3.83% | 796,408 | - |
| 350 | NUTX | Nutex Health Inc. | 1.18B | -9.40% | 197,122 | 796.53M |
| 351 | AHG | Akso Health Group | 1.15B | -0.37% | 1,461 | 13.83M |
| 352 | FRNM | Freenome, Inc. | 1.14B | -8.22% | 904,299 | 217.86M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.12B | -2.84% | 1,072,720 | 1.66B |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.11B | -4.72% | 54,416 | - |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.10B | -4.74% | 1,519,291 | - |
| 356 | ATEC | Alphatec Holdings, Inc. | 1.10B | -3.95% | 5,393,276 | 839.72M |
| 357 | IRMD | IRADIMED CORPORATION | 1.09B | -1.56% | 71,654 | 89.34M |
| 358 | SIBN | SI-BONE, Inc. | 1.09B | -3.21% | 744,279 | 220.65M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -5.54% | 228,591 | - |
| 360 | VSTM | Verastem, Inc. | 1.06B | -7.15% | 2,089,347 | 100.30M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.06B | 1.50% | 440,802 | 377.13M |
| 362 | HROW | Harrow, Inc. | 1.06B | -3.64% | 551,147 | 303.25M |
| 363 | AHCO | AdaptHealth Corp. | 1.05B | 0.90% | 2,979,583 | 3.44B |
| 364 | CBLL | CeriBell, Inc. | 1.02B | -5.22% | 480,060 | 108.72M |
| 365 | GMRS | GMR Solutions Inc. | 1.02B | -3.91% | 1,484,663 | 5.97B |
| 366 | JBIO | Jade Biosciences, Inc. | 1.01B | -4.05% | 880,377 | - |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 963.62M | -4.24% | 321,973 | 99.00K |
| 368 | AORT | Artivion, Inc. | 946.52M | -3.48% | 855,188 | 481.88M |
| 369 | CTY | City Therapeutics, Inc. | 944.38M | 11.58% | 216,894 | 14.34M |
| 370 | IVA | Inventiva S.A. | 936.71M | -3.24% | 2,503,731 | 2.81M |
| 371 | BVS | Bioventus Inc. | 915.07M | -1.18% | 565,984 | 585.64M |
| 372 | OMDA | Omada Health, Inc. | 911.95M | -3.54% | 880,673 | 333.04M |
| 373 | PHAR | Pharming Group N.V. | 909.09M | -3.36% | 12,645 | 386.75M |
| 374 | AKTS | Aktis Oncology, Inc. | 905.49M | -4.46% | 245,510 | 12.39M |
| 375 | BBNX | Beta Bionics, Inc. | 897.60M | -7.30% | 982,438 | 127.27M |
| 376 | CRVS | Corvus Pharmaceuticals, Inc. | 895.83M | -7.41% | 1,021,499 | - |
| 377 | IMTX | Immatics N.V. | 891.22M | -2.54% | 809,266 | 49.33M |
| 378 | ORIC | ORIC Pharmaceuticals, Inc. | 881.05M | -5.56% | 1,178,750 | - |
| 379 | HSTM | HealthStream, Inc. | 866.61M | -2.04% | 183,241 | 327.95M |
| 380 | RIGL | Rigel Pharmaceuticals, Inc. | 860.34M | 2.63% | 325,687 | 288.21M |
| 381 | MGTX | MeiraGTx Holdings plc | 859.05M | -9.19% | 1,363,144 | 401.91M |
| 382 | SNDX | Syndax Pharmaceuticals, Inc. | 858.87M | -0.52% | 2,830,163 | 289.68M |
| 383 | LTGO | Latigo Biotherapeutics, Inc. | 857.25M | -4.36% | 167,665 | - |
| 384 | BBTX | Bambusa Therapeutics, Inc. | 853.29M | -2.39% | 94,802 | - |
| 385 | KIDS | OrthoPediatrics Corp. | 850.68M | -3.24% | 165,825 | 264.14M |
| 386 | LXRX | Lexicon Pharmaceuticals, Inc. | 810.33M | -2.67% | 1,685,719 | 38.54M |
| 387 | IRWD | Ironwood Pharmaceuticals, Inc. | 802.92M | -0.41% | 3,568,998 | 400.30M |
| 388 | ALMS | Alumis Inc. | 795.80M | -7.40% | 1,864,094 | 7.24M |
| 389 | GLUE | Monte Rosa Therapeutics, Inc. | 795.54M | -9.70% | 1,245,711 | 70.33M |
| 390 | ARDX | Ardelyx, Inc. | 784.28M | -0.32% | 4,034,894 | 468.22M |
| 391 | PHR | Phreesia, Inc. | 783.34M | -1.48% | 774,497 | 507.79M |
| 392 | SLDB | Solid Biosciences Inc. | 781.27M | -7.89% | 1,322,916 | - |
| 393 | SGMT | Sagimet Biosciences Inc. | 780.05M | -4.21% | 1,441,416 | - |
| 394 | COLL | Collegium Pharmaceutical, Inc. | 775.33M | 0.56% | 479,895 | 815.19M |
| 395 | OBX | Obsidian Therapeutics, Inc. | 770.93M | -3.11% | 328,742 | - |
| 396 | VREX | Varex Imaging Corporation | 770.04M | -0.65% | 948,448 | 865.00M |
| 397 | INMD | InMode Ltd. | 758.17M | -3.93% | 796,475 | 373.60M |
| 398 | ANNX | Annexon, Inc. | 757.33M | -5.25% | 4,465,607 | - |
| 399 | DCTH | Delcath Systems, Inc. | 743.77M | -1.79% | 1,091,856 | 109.96M |
| 400 | AURA | Aura Biosciences, Inc. | 739.97M | -6.57% | 1,006,709 | - |
| 401 | DBVT | DBV Technologies S.A. | 736.60M | -3.79% | 337,294 | 3.74M |
| 402 | QDEL | QuidelOrtho Corporation | 728.67M | -10.83% | 1,436,332 | 2.59B |
| 403 | OABI | OmniAb, Inc. | 722.01M | -2.94% | 1,403,473 | 40.21M |
| 404 | CTKB | Cytek Biosciences, Inc. | 721.93M | -4.17% | 789,062 | 207.65M |
| 405 | ATTO | Attovia Therapeutics, Inc. | 721.75M | -5.50% | 222,108 | 1.44M |
| 406 | IAM | Iambic Therapeutics, Inc. | 703.43M | -3.57% | 490,507 | 18.25M |
| 407 | JANX | Janux Therapeutics, Inc. | 703.30M | -7.22% | 1,169,154 | 23.29M |
| 408 | NVCT | Nuvectis Pharma, Inc. | 695.69M | -3.67% | 206,615 | - |
| 409 | FLGT | Fulgent Genetics, Inc. | 694.28M | -3.31% | 287,391 | 330.28M |
| 410 | PRME | Prime Medicine, Inc. | 694.17M | -9.53% | 7,173,243 | 7.06M |
| 411 | APMD | Apnimed, Inc. | 692.32M | -0.89% | 278,810 | 115.12M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 683.04M | -6.74% | 897,223 | 96.06M |
| 413 | KURA | Kura Oncology, Inc. | 682.66M | -3.88% | 2,844,665 | 79.31M |
| 414 | DSGN | Design Therapeutics, Inc. | 677.50M | -1.76% | 502,505 | - |
| 415 | ANL | Adlai Nortye Group Ltd. | 677.47M | -3.04% | 130,646 | 18.06M |
| 416 | AVBP | ArriVent BioPharma, Inc. | 676.02M | -3.26% | 793,949 | 5.00M |
| 417 | SOPH | SOPHiA GENETICS SA | 673.27M | 5.22% | 732,913 | 90.97M |
| 418 | BCAX | Bicara Therapeutics Inc. | 671.17M | -3.99% | 1,891,564 | - |
| 419 | IMMX | Immix Biopharma, Inc. | 669.03M | -6.81% | 960,302 | - |
| 420 | ZVRA | Zevra Therapeutics, Inc. | 664.07M | -5.82% | 823,693 | 147.76M |
| 421 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.08M | -0.20% | 2,498,308 | 130.75M |
| 422 | CGEM | Cullinan Therapeutics, Inc. | 661.54M | -10.22% | 1,135,512 | - |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 658.80M | -6.47% | 1,996,919 | - |
| 424 | CADL | Candel Therapeutics, Inc. | 658.16M | -9.00% | 1,935,346 | - |
| 425 | HELP | Helus Pharma Inc. | 647.31M | -5.64% | 1,117,002 | - |
| 426 | GERN | Geron Corporation | 640.37M | -2.55% | 10,354,730 | 217.52M |
| 427 | CLYM | Climb Bio, Inc. | 638.48M | -11.27% | 1,346,460 | - |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 634.45M | -7.83% | 1,956,665 | 6.40M |
| 429 | WVE | Wave Life Sciences, Inc. | 622.26M | -7.75% | 2,473,305 | 70.92M |
| 430 | ABUS | Arbutus Biopharma Corporation | 617.77M | 3.87% | 3,954,913 | 181.49M |
| 431 | PACB | Pacific Biosciences of California, Inc. | 616.47M | -5.74% | 10,335,848 | 161.39M |
| 432 | CBIO | Crescent Biopharma, Inc. | 615.05M | -2.64% | 209,893 | 15.00M |
| 433 | EVO | Evotec SE | 614.05M | -1.78% | 47,083 | 815.72M |
| 434 | SGHT | Sight Sciences, Inc. | 610.81M | 0.64% | 459,128 | 88.40M |
| 435 | SRZN | Surrozen, Inc. | 603.68M | -0.66% | 134,043 | 10.53M |
| 436 | SANA | Sana Biotechnology, Inc. | 602.27M | -12.23% | 3,687,031 | - |
| 437 | TCMD | Tactile Systems Technology, Inc. | 600.80M | -1.14% | 252,719 | 356.42M |
| 438 | CAPR | Capricor Therapeutics, Inc. | 595.38M | -8.73% | 4,779,308 | 11.13M |
| 439 | ETRA | Electra Therapeutics, Inc. | 571.81M | -3.60% | 545,284 | - |
| 440 | AVR | Anteris Technologies Global Corp. | 571.31M | -5.48% | 965,163 | 2.33M |
| 441 | NRC | NRC Health | 565.34M | -0.82% | 93,361 | 143.79M |
| 442 | ENTX | Entera Bio Ltd. | 560.72M | 0.00% | 170,484 | 42.00K |
| 443 | VALN | Valneva SE | 553.74M | -2.70% | 5,550 | 163.30M |
| 444 | SENS | Senseonics Holdings, Inc. | 550.00M | -3.65% | 921,208 | 60.01M |
| 445 | MYGN | Myriad Genetics, Inc. | 544.84M | -0.70% | 1,409,199 | 803.60M |
| 446 | EVH | Evolent Health, Inc. | 539.51M | -4.41% | 1,394,867 | 2.34B |
| 447 | RGNX | REGENXBIO Inc. | 530.96M | -5.19% | 1,286,213 | 153.91M |
| 448 | TKNO | Alpha Teknova, Inc. | 521.78M | -3.77% | 380,448 | 45.95M |
| 449 | SRTA | Strata Critical Medical, Inc. | 515.38M | -3.99% | 1,030,391 | 280.76M |
| 450 | EPRX | Eupraxia Pharmaceuticals Inc. | 513.57M | -3.10% | 398,539 | - |
| 451 | ANGO | AngioDynamics, Inc. | 504.02M | -3.50% | 317,318 | 325.38M |
| 452 | DMAC | DiaMedica Therapeutics Inc. | 503.42M | -3.42% | 187,771 | - |
| 453 | RCEL | AVITA Medical, Inc. | 501.01M | -6.36% | 495,817 | 84.68M |
| 454 | PHAT | Phathom Pharmaceuticals, Inc. | 494.85M | -0.80% | 1,087,627 | 274.88M |
| 455 | NGNE | Neurogene Inc. | 494.75M | -4.78% | 237,853 | 925.00K |
| 456 | MNPR | Monopar Therapeutics Inc. | 492.54M | 1.32% | 313,027 | - |
| 457 | STTK | Shattuck Labs, Inc. | 489.86M | -4.75% | 1,320,432 | 1.00M |
| 458 | OBIO | Orchestra BioMed Holdings, Inc. | 484.04M | 2.33% | 631,084 | 31.21M |
| 459 | INDP | Indaptus Therapeutics, Inc. | 483.78M | -1.87% | 118,325 | - |
| 460 | OVID | Ovid Therapeutics Inc. | 481.27M | -8.27% | 2,924,932 | 1.45M |
| 461 | EOLS | Evolus, Inc. | 475.23M | -3.23% | 737,093 | 325.47M |
| 462 | CARL | Carlsmed, Inc. | 474.09M | -6.99% | 384,833 | 71.78M |
| 463 | KMDA | Kamada Ltd. | 473.95M | 0.00% | 91,442 | 196.87M |
| 464 | MDXG | MiMedx Group, Inc. | 472.80M | -2.41% | 1,474,681 | 303.73M |
| 465 | BLSM | BlossomHill Therapeutics, Inc. | 471.69M | -7.94% | 256,384 | - |
| 466 | GYRE | Gyre Therapeutics, Inc. | 470.64M | 0.94% | 173,995 | 110.06M |
| 467 | OCS | Oculis Holding AG | 462.99M | -1.45% | 299,110 | 1.12M |
| 468 | CTEV | Claritev Corporation | 459.31M | -4.64% | 240,382 | 1.02B |
| 469 | ARVN | Arvinas, Inc. | 449.88M | -0.58% | 923,734 | 275.30M |
| 470 | AQST | Aquestive Therapeutics, Inc. | 448.71M | -0.28% | 2,795,618 | 48.84M |
| 471 | AVTX | Avalo Therapeutics, Inc. | 445.24M | -9.52% | 2,960,581 | 59.00K |
| 472 | CTMX | CytomX Therapeutics, Inc. | 444.73M | -4.23% | 3,156,864 | 14.03M |
| 473 | RLMD | Relmada Therapeutics, Inc. | 443.85M | -6.09% | 1,038,538 | - |
| 474 | MOBI | Mobia Medical, Inc. | 443.59M | -1.19% | 229,960 | 51.89M |
| 475 | SI | Shoulder Innovations, Inc. | 441.05M | -3.83% | 95,714 | 64.49M |
| 476 | SLBT | SL Science Holding Limited | 435.85M | 5.80% | 26,716 | 3.27M |
| 477 | PRTA | Prothena Corporation plc | 422.61M | -5.73% | 237,031 | 52.74M |
| 478 | PBYI | Puma Biotechnology, Inc. | 417.72M | 0.00% | 448,734 | 231.83M |
| 479 | BWAY | BrainsWay Ltd. | 416.03M | -8.81% | 203,753 | 60.70M |
| 480 | NPCE | NeuroPace, Inc. | 414.11M | -3.99% | 156,665 | 106.75M |
| 481 | TECX | Tectonic Therapeutic, Inc. | 411.32M | -4.19% | 121,954 | - |
| 482 | ASMB | Assembly Biosciences, Inc. | 411.03M | -9.79% | 499,584 | 67.01M |
| 483 | MASS | 908 Devices Inc. | 407.09M | -2.68% | 415,584 | 65.79M |
| 484 | RZLT | Rezolute, Inc. | 405.98M | -4.91% | 1,089,288 | - |
| 485 | ASPE | Aspen Neuroscience, Inc. | 395.76M | -1.52% | 267,365 | - |
| 486 | MPLT | MapLight Therapeutics, Inc. | 392.92M | -5.48% | 266,221 | - |
| 487 | IRD | Opus Genetics, Inc. | 392.42M | -5.80% | 1,388,024 | 7.91M |
| 488 | CERS | Cerus Corporation | 391.79M | -8.49% | 1,616,227 | 226.57M |
| 489 | CRMD | CorMedix Inc. | 384.96M | -8.68% | 3,681,872 | 412.49M |
| 490 | LYEL | Lyell Immunopharma, Inc. | 384.52M | -7.24% | 130,957 | 15.00K |
| 491 | CTNM | Contineum Therapeutics, Inc. | 384.02M | -9.19% | 315,430 | - |
| 492 | FENC | Fennec Pharmaceuticals Inc. | 383.84M | 2.44% | 284,814 | 66.37M |
| 493 | SPRY | ARS Pharmaceuticals, Inc. | 383.01M | -3.54% | 2,289,243 | 122.14M |
| 494 | STLN | Starling Oncology, Inc. | 382.47M | -10.71% | 6,548,787 | 620.45M |
| 495 | TRXB | TRex Bio, Inc. | 379.60M | -1.05% | 45,616 | - |
| 496 | YDES | YD Bio Limited | 367.97M | -15.53% | 79,430 | 1.24M |
| 497 | TLRY | Tilray Brands, Inc. | 365.19M | -4.60% | 3,733,164 | 963.10M |
| 498 | ALEC | Alector, Inc. | 364.75M | -6.84% | 1,872,049 | 173.47M |
| 499 | EMBC | Embecta Corp. | 364.32M | -1.53% | 973,986 | 1.02B |
| 500 | CCCC | C4 Therapeutics, Inc. | 363.75M | -4.15% | 4,967,246 | 32.28M |